Advertisement
Organisation › Details
IP Group plc (LSE: IPO)
IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiary IP Capital), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in approximately 80 early-stage to mature businesses across four main sectors -- Biotech, Cleantech, Healthcare and Technology. The Company is listed on the Main Market of the London Stock Exchange under the code IPO. *
Start | 2006-04-26 renamed | |
Group | IP Group (Group) | |
Predecessor | IP2IPO Group plc | |
Industry | IP services | |
Industry 2 | venture capital | |
Person | Smith, Greg (IP Group 2022 CEO before CFO) | |
Person 2 | Baynes, David (IP Group 202112 CFO formerly Fusion IP + Biofusion) | |
Region | London, Greater London | |
Country | United Kingdom (GB) | |
Street | 24 Cornhill | |
City | EC3V 3ND London | |
Tel | +44-845-074-2929 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | C: 51 to 100 (2021-12-31) |
Currency | GBP | |
Annual sales | 508,900,000 (portfolio return + revenue, consolidated (2021) 2021-12-31) | |
Profit | 449,300,000 (2021-12-31) | |
Cash | 105,700,000 (2021-12-31) | |
* Document for »About Section«: | ||
Record changed: 2024-01-30 |
Advertisement
More documents for IP Group (Group)
- [1] IP Group plc. (5/4/21). "Press Release: Portfolio Company Oxford Nanopore Technologies Raises £195m in New Investment"....
- [2] Mogrify Ltd.. (5/4/21). "Press Release: Mogrify Completes Series A financing Totaling $33 Million USD". Cambridge....
- [3] Genomics plc. (8/30/18). "Press Release: Genomics plc Raises £25 million in Series B Round to Advance Its Use of Human Genetics and Data Science in Drug Discovery". Oxford....
- [4] IP Group plc. (5/15/18). "Press Release: IP Group and Johns Hopkins Collaboration Funds Cancer Therapeutic Start-up"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top